2019: August 20, Science Signaling Cover Story
Drug Resistance Group identifies a novel 3-drug combination by targeting the glucose-6-phosphate dehydrogenase during metabolic remodeling. Visit the article
Drug Resistance Group identifies a novel 3-drug combination by targeting the glucose-6-phosphate dehydrogenase during metabolic remodeling. Visit the article
In collaboration with Dr. Martin Nowak, we describe a novel mechanism of drug-induced resistance, which emerges through clonal cooperation dynamics in heterogeneous cancers. Read the article!